[{"address1": "11711 North Meridian Street", "address2": "Suite 300", "city": "Carmel", "state": "IN", "zip": "46032", "country": "United States", "phone": "(317) 659-0200", "website": "https://mbxbio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "MBX Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the treatment of endocrine and metabolic disorders. Its lead product candidate is MBX 2109, a parathyroid hormone peptide prodrug, which is in Phase 2 clinical trial for the treatment of chronic hypoparathyroidism. The company is also developing MBX 1416, a long-acting glucagon-like peptide-1 (GLP-1) receptor antagonist that is in Phase 1 clinical trial a potential therapy for post-bariatric hypoglycemia, a chronic complication of bariatric surgery. In addition, it is developing MBX 4291, a lead obesity product candidate, which is in investigational new drug-enabling studies for the treatment of obesity and co-morbidities. The company was founded in 2018 and is based in Carmel, Indiana.", "fullTimeEmployees": 43, "companyOfficers": [{"maxAge": 1, "name": "Mr. Peter Kent Hawryluk MBA", "age": 55, "title": "CEO, President & Director", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 788300, "exercisedValue": 0, "unexercisedValue": 12366896}, {"maxAge": 1, "name": "Mr. Richard B. Bartram CPA", "age": 43, "title": "Chief Financial Officer", "yearBorn": 1981, "fiscalYear": 2024, "totalPay": 642001, "exercisedValue": 0, "unexercisedValue": 3084960}, {"maxAge": 1, "name": "Dr. Salomon  Azoulay M.D.", "age": 66, "title": "Chief Medical Officer", "yearBorn": 1958, "fiscalYear": 2024, "totalPay": 520512, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Matt  Gambino", "title": "Vice President of Marketing", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Michelle  Graham", "age": 57, "title": "Chief Human Resources Officer", "yearBorn": 1967, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael A. Dorato DABT, Ph.D.", "title": "Sr. Vice President of Discovery & Non-Clinical Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Chatan  Charan Ph.D.", "title": "Senior VP of Pharmaceutical Development & Chemistry, Manufacturing and Controls", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mark  Hope", "title": "Senior Vice President of Regulatory & Quality", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 10.83, "open": 10.84, "dayLow": 10.5, "dayHigh": 11.62, "regularMarketPreviousClose": 10.83, "regularMarketOpen": 10.84, "regularMarketDayLow": 10.5, "regularMarketDayHigh": 11.62, "payoutRatio": 0.0, "forwardPE": -4.9656653, "volume": 42495, "regularMarketVolume": 42495, "averageVolume": 290955, "averageVolume10days": 302160, "averageDailyVolume10Day": 302160, "bid": 8.31, "ask": 13.87, "bidSize": 2, "askSize": 2, "marketCap": 386720288, "fiftyTwoWeekLow": 4.807, "fiftyTwoWeekHigh": 27.5, "fiftyDayAverage": 8.657, "twoHundredDayAverage": 15.378889, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 100007936, "profitMargins": 0.0, "floatShares": 13610404, "sharesOutstanding": 33424400, "sharesShort": 5358941, "sharesShortPriorMonth": 4568242, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.1603, "heldPercentInsiders": 0.03115, "heldPercentInstitutions": 0.99192, "shortRatio": 15.55, "shortPercentOfFloat": 0.3224, "impliedSharesOutstanding": 33424400, "bookValue": 7.703, "priceToBook": 1.5020121, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -61922000, "trailingEps": -5.82, "forwardEps": -2.33, "enterpriseToEbitda": -1.472, "52WeekChange": -0.5420719, "SandP52WeekChange": 0.08001411, "quoteType": "EQUITY", "currentPrice": 11.57, "targetHighPrice": 44.0, "targetLowPrice": 30.0, "targetMeanPrice": 37.4, "targetMedianPrice": 38.0, "recommendationKey": "none", "numberOfAnalystOpinions": 5, "totalCash": 262148992, "totalCashPerShare": 7.843, "ebitda": -67950000, "totalDebt": 171000, "quickRatio": 23.783, "currentRatio": 24.187, "debtToEquity": 0.066, "returnOnAssets": -0.24168, "returnOnEquity": -0.36713, "freeCashflow": -33270250, "operatingCashflow": -54681000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "MBX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "longName": "MBX Biosciences, Inc.", "marketState": "REGULAR", "cryptoTradeable": false, "regularMarketChangePercent": 6.8328695, "regularMarketPrice": 11.57, "corporateActions": [], "regularMarketTime": 1746723047, "exchange": "NMS", "messageBoardId": "finmb_613097171", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 290955, "fiftyTwoWeekLowChange": 6.7629995, "fiftyTwoWeekLowChangePercent": 1.4069065, "fiftyTwoWeekRange": "4.807 - 27.5", "fiftyTwoWeekHighChange": -15.93, "fiftyTwoWeekHighChangePercent": -0.57927275, "fiftyTwoWeekChangePercent": -54.207188, "earningsTimestamp": 1742212803, "earningsTimestampStart": 1742212803, "earningsTimestampEnd": 1742212803, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -5.82, "epsForward": -2.33, "epsCurrentYear": -2.77222, "priceEpsCurrentYear": -4.1735506, "fiftyDayAverageChange": 2.913, "fiftyDayAverageChangePercent": 0.33649072, "twoHundredDayAverageChange": -3.8088894, "twoHundredDayAverageChangePercent": -0.24767, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2024-09-13", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1726234200000, "regularMarketChange": 0.7399998, "regularMarketDayRange": "10.5 - 11.62", "shortName": "MBX Biosciences, Inc.", "displayName": "MBX Biosciences", "trailingPegRatio": null, "__fetch_time": "2025-05-08"}]